Bicara Therapeutics
BCAX • XNAS • Stock Fundamentals
Bicara Therapeutics is a pharmaceutical preparations company trading on XNAS, led by CEO Claire Mazumdar Clemon, with a market cap of $1.4B.
Market Cap$1.4B
CEOClaire Mazumdar Clemon
CountryUnited States of America
PHARMACEUTICAL PREPARATIONS
Most Recent EarningsMay 11, 2026 · 17 days agoQ1 2026
View reportNext EarningsAug 11, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Bicara Therapeutics FAQ
Common questions about Bicara Therapeutics
Bicara Therapeutics (BCAX) has a market capitalization of $1.4B and trades on XNAS.